Feb. 19 at 9:50 PM
$CC Q4 '25 Earnings Results & Recap
• Reported GAAP EPS of -
$0.31 down -287.50% YoY
• Reported revenue of
$1.33B down -2.13% YoY
• Chemours expects 2026 Net Sales growth of 3% to 5% and Adjusted EBITDA between
$800M and
$900M, driven by increased TSS and APM demand. Chemours also anticipates Free Cash Flow Conversion above 25% for the full year.